Clinical Trial Update: Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating octanoate breath test for detecting hepatocellular carcinoma compared with MRI; study terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Disease

Drugs mentioned

• MRI
• Octanoate breath test

Snippet

Sponsor: Meridian Bioscience, Inc. | Conditions: Chronic Liver Disease, Hepatocellular Carcinoma (HCC) | Phase 2 | Status: TERMINATED | Results posted: 2014-04-07